Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Izzo

Showing results (111-120 of 287) with videos related to

Pageof 29
Sort By:
Hypertension (Dallas, Tex. : 1979)|July 16, 1999
Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitusB H Sung, J L Izzo, P Dandona, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2006
Prehypertension--what is it and should it be treated?Marvin Moser, Thomas D Giles, Joseph L Izzo, et al.
American Journal of Hypertension|May 1, 1990
Hemodynamics of seasonal adaptationJ L Izzo, P S Larrabee, E Sander, et al.
Il Giornale Di Chirurgia|May 1, 1989
[Ultrasonography and biliary calculi: a retrospective study on the diagnostic reliability]T Bocchetti, L Caramanico, M M Benedettini, et al.
Critical Care Medicine|May 1, 1983
Protective effects of beta blockade on pulmonary function when intracranial pressure is elevatedF J Colgan, T Sawa, L G Teneyck, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 31, 2007
First-step use of fixed-dose combination treatment in stage 2 hypertensive patients: has the time come?Michael A Weber, Luis Ruilope, Thomas D Giles, et al.
Journal of Human Hypertension|July 29, 2016
Hypertension and aging in rural Haiti: results from a preliminary surveyV B Polsinelli, N Satchidanand, R Singh, et al.
Minerva Chirurgica|November 30, 1988
[Neodymium-Yag laser in the treatment of inoperable tumors of the trachea and the large bronchi]L Izzo, R Rizzo, L Caramanico, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Efficacy and safety of treating stage 2 systolic hypertension with olmesartan and olmesartan/HCTZ: results of an open-label titration studyJoseph L Izzo, Joel M Neutel, Tonous Silfani, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Titration of HCTZ to 50 mg daily in individuals with stage 2 systolic hypertension pretreated with an angiotensin receptor blockerJoseph L Izzo, Joel M Neutel, Tonous Silfani, et al.
Pageof 29

Showing results (111-120 of 287) with videos related to

Sort By:
Pageof 29
Hypertension (Dallas, Tex. : 1979)|July 16, 1999
Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitusB H Sung, J L Izzo, P Dandona, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2006
Prehypertension--what is it and should it be treated?Marvin Moser, Thomas D Giles, Joseph L Izzo, et al.
American Journal of Hypertension|May 1, 1990
Hemodynamics of seasonal adaptationJ L Izzo, P S Larrabee, E Sander, et al.
Il Giornale Di Chirurgia|May 1, 1989
[Ultrasonography and biliary calculi: a retrospective study on the diagnostic reliability]T Bocchetti, L Caramanico, M M Benedettini, et al.
Critical Care Medicine|May 1, 1983
Protective effects of beta blockade on pulmonary function when intracranial pressure is elevatedF J Colgan, T Sawa, L G Teneyck, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 31, 2007
First-step use of fixed-dose combination treatment in stage 2 hypertensive patients: has the time come?Michael A Weber, Luis Ruilope, Thomas D Giles, et al.
Journal of Human Hypertension|July 29, 2016
Hypertension and aging in rural Haiti: results from a preliminary surveyV B Polsinelli, N Satchidanand, R Singh, et al.
Minerva Chirurgica|November 30, 1988
[Neodymium-Yag laser in the treatment of inoperable tumors of the trachea and the large bronchi]L Izzo, R Rizzo, L Caramanico, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Efficacy and safety of treating stage 2 systolic hypertension with olmesartan and olmesartan/HCTZ: results of an open-label titration studyJoseph L Izzo, Joel M Neutel, Tonous Silfani, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 12, 2007
Titration of HCTZ to 50 mg daily in individuals with stage 2 systolic hypertension pretreated with an angiotensin receptor blockerJoseph L Izzo, Joel M Neutel, Tonous Silfani, et al.
Pageof 29